FORM 8-K

                      SECURITIES AND EXCHANGE COMMISSION

                            Washington, D.C.  20549



                      ----------------------------------



                                CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


                       DATE OF REPORT: JANUARY 17, 2002
                       (Date of earliest event reported)


                          KIMBERLY-CLARK CORPORATION
            (Exact name of registrant as specified in its charter)


     DELAWARE                            1-225              39-0394230

     (State or other jurisdiction     (Commission File     (IRS Employer
        of incorporation)               Number)            Identification No.)


          P.O. BOX 619100, DALLAS, TEXAS                    75261-9100
          (Address of principal executive offices)          (Zip Code)


                                (972) 281-1200
             (Registrant's telephone number, including area code)


                      ----------------------------------




Item 9. Regulation FD Disclosure
--------------------------------

Attached hereto as Exhibit 99 is a summary of Kimberly-Clark Corporation's
(the "Company") sales and operating profit by business segment for 1999, 2000
and the first nine months of 2001. This information reflects the newly defined
business segments of the Company as a result of recent organizational changes.
The new business segments are Personal Care, Consumer Tissue and Business to
Business.

The reclassifications of historical financial information are consistent with
the Company's  announcement during a November 30, 2001 web-casted conference
call. Sales and operating profit of K-C Professional and Neenah Paper have
been removed from the former Tissue segment and included in the new Business to
Business segment along with the Company's Health Care, Nonwovens and Technical
Paper operations that formerly constituted the Health Care and Other segment.
The now smaller Tissue segment has been renamed Consumer Tissue. The Personal
Care segment has not changed.


                                   SIGNATURE
                                   ---------

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                                    KIMBERLY-CLARK CORPORATION


Date: January 17, 2002                        By: /s/John W Donehower
                                                  ----------------------------
                                                     John W. Donehower
                                                     Senior Vice President and
                                                     Chief Financial Officer



                                 EXHIBIT INDEX
                                 -------------


(99)   Sales and Operating Profit by Business Segment (as reclassified) for
       1999, 2000 and the first nine months of 2001.